207 related articles for article (PubMed ID: 23648464)
1. A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors.
Handorf CR; Kulkarni A; Grenert JP; Weiss LM; Rogers WM; Kim OS; Monzon FA; Halks-Miller M; Anderson GG; Walker MG; Pillai R; Henner WD
Am J Surg Pathol; 2013 Jul; 37(7):1067-75. PubMed ID: 23648464
[TBL] [Abstract][Full Text] [Related]
2. Comparison of histopathology to gene expression profiling for the diagnosis of metastatic cancer.
Kulkarni A; Pillai R; Ezekiel AM; Henner WD; Handorf CR
Diagn Pathol; 2012 Aug; 7():110. PubMed ID: 22909314
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care.
Hainsworth JD; Greco FA
Virchows Arch; 2014 Apr; 464(4):393-402. PubMed ID: 24487792
[TBL] [Abstract][Full Text] [Related]
4. Benefit of Gene Expression Profiling in Gastrointestinal Neuroendocrine Tumors of Unknown Primary Origin.
Saller JJ; Haider M; Al-Diffalha S; Coppola D
Anticancer Res; 2022 Mar; 42(3):1381-1396. PubMed ID: 35220231
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology.
Greco FA; Lennington WJ; Spigel DR; Hainsworth JD
J Natl Cancer Inst; 2013 Jun; 105(11):782-90. PubMed ID: 23641043
[TBL] [Abstract][Full Text] [Related]
6. Comparison of histopathological and gene expression-based typing of cancer of unknown primary.
Morawietz L; Floore A; Stork-Sloots L; Folprecht G; Buettner R; Rieger A; Dietel M; Huebner G
Virchows Arch; 2010 Jan; 456(1):23-9. PubMed ID: 20012089
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiles help identify the tissue of origin for metastatic brain cancers.
Wu AH; Drees JC; Wang H; VandenBerg SR; Lal A; Henner WD; Pillai R
Diagn Pathol; 2010 Apr; 5():26. PubMed ID: 20420692
[TBL] [Abstract][Full Text] [Related]
8. [Comparing immunohistochemical diagnosis of cancer of unknown primary with gene expression-based tumor classification].
Morawietz L; Floore A; Stork-Sloots L; Folprecht G; Buettner R; Rieger A; Dietel M; Huebner G
Pathologe; 2009 Dec; 30 Suppl 2():168-72. PubMed ID: 19756615
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of gene-expression profiling for tumor-site origin in patients with metastatic or poorly differentiated cancer: impact on diagnosis, treatment, and survival.
Nystrom SJ; Hornberger JC; Varadhachary GR; Hornberger RJ; Gutierrez HR; Henner DW; Becker SH; Amin MB; Walker MG
Oncotarget; 2012 Jun; 3(6):620-8. PubMed ID: 22689213
[TBL] [Abstract][Full Text] [Related]
10. Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens.
Pillai R; Deeter R; Rigl CT; Nystrom JS; Miller MH; Buturovic L; Henner WD
J Mol Diagn; 2011 Jan; 13(1):48-56. PubMed ID: 21227394
[TBL] [Abstract][Full Text] [Related]
11. Poorly differentiated neoplasms of unknown primary site: diagnostic usefulness of a molecular cancer classifier assay.
Greco FA; Lennington WJ; Spigel DR; Hainsworth JD
Mol Diagn Ther; 2015 Apr; 19(2):91-7. PubMed ID: 25758902
[TBL] [Abstract][Full Text] [Related]
12. An integrated tool for determining the primary origin site of metastatic tumours.
Santos MTD; Souza BF; Cárcano FM; Vidal RO; Scapulatempo-Neto C; Viana CR; Carvalho AL
J Clin Pathol; 2018 Jul; 71(7):584-593. PubMed ID: 29248889
[TBL] [Abstract][Full Text] [Related]
13. A 92-gene cancer classifier predicts the site of origin for neuroendocrine tumors.
Kerr SE; Schnabel CA; Sullivan PS; Zhang Y; Huang VJ; Erlander MG; Brachtel EF; Dry SM
Mod Pathol; 2014 Jan; 27(1):44-54. PubMed ID: 23846576
[TBL] [Abstract][Full Text] [Related]
14. Renal Cell Carcinoma Presenting as Carcinoma of Unknown Primary Site: Recognition of a Treatable Patient Subset.
Greco FA; Hainsworth JD
Clin Genitourin Cancer; 2018 Aug; 16(4):e893-e898. PubMed ID: 29610002
[TBL] [Abstract][Full Text] [Related]
15. Accurate classification of metastatic brain tumors using a novel microRNA-based test.
Mueller WC; Spector Y; Edmonston TB; St Cyr B; Jaeger D; Lass U; Aharonov R; Rosenwald S; Chajut A
Oncologist; 2011; 16(2):165-74. PubMed ID: 21273512
[TBL] [Abstract][Full Text] [Related]
16. A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin.
Yan N; Zhang Y; Guo X; Yuan D; Tian G; Yang J
Methods Mol Biol; 2020; 2204():109-119. PubMed ID: 32710319
[TBL] [Abstract][Full Text] [Related]
17. Blinded comparator study of immunohistochemical analysis versus a 92-gene cancer classifier in the diagnosis of the primary site in metastatic tumors.
Weiss LM; Chu P; Schroeder BE; Singh V; Zhang Y; Erlander MG; Schnabel CA
J Mol Diagn; 2013 Mar; 15(2):263-9. PubMed ID: 23287002
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer transcriptome analysis reveals a gene expression signature for the identification of tumor tissue origin.
Xu Q; Chen J; Ni S; Tan C; Xu M; Dong L; Yuan L; Wang Q; Du X
Mod Pathol; 2016 Jun; 29(6):546-56. PubMed ID: 26990976
[TBL] [Abstract][Full Text] [Related]
19. A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors.
Maxwell JE; Sherman SK; Stashek KM; O'Dorisio TM; Bellizzi AM; Howe JR
Surgery; 2014 Dec; 156(6):1359-65; discussion 1365-6. PubMed ID: 25456909
[TBL] [Abstract][Full Text] [Related]
20. Clinical verification of the performance of the pathwork tissue of origin test: utility and limitations.
Dumur CI; Fuller CE; Blevins TL; Schaum JC; Wilkinson DS; Garrett CT; Powers CN
Am J Clin Pathol; 2011 Dec; 136(6):924-33. PubMed ID: 22095379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
